Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC has approved the listing of the Company's common shares on... Read More

Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal to Complete Nasdaq Uplisting by Year-End Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that management has been invited to attend the LD Micro Main Event XVII Conference taking place on October 30, 2024. CEO Ilan Sobel is scheduled to host one-on-one... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company's management team, continuing to serve as Vice President of Investor Relations of the Company. Mr. Ryan resigned as a director of the... Read More

RALEIGH, NC / ACCESSWIRE / September 20, 2024 / iAccess Alpha's "Buyside Best Ideas Virtual Fall Conference" is taking place on September 24-25, 2024. The conference begins on Tuesday, September 24, with Company presentations beginning at 9:30 a.m. Eastern Time. Company presentations will be webcast live online on Tuesday September 24. 1x1 Meetings are being held all-day Wednesday September 25 beginning at 8:00 a.m. Eastern... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024. CEO Ilan Sobel is scheduled to host... Read More

New York, New York, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on BioHarvest Sciences Inc. (OTCQB: CNVCF, CNSX: BHSC). The update note includes detailed information on the BioHarvest Sciences’ financial results, operational updates, business model, management commentary, valuation, and risks. The... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - B ioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26 th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New... Read More

Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+ Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC)... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee , a "functional"... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024. On the call, CEO Ilan Sobel will discuss commercial progress and new product marketing... Read More

NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of BioHarvest Sciences Inc. (OTCQB: CNVCF, CSE: BHSC). The in-depth 35-page initiation report includes detailed information on the BioHarvest Sciences’ business model, services, industry, valuation, management, and risks. The full research report is... Read More

Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 30, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)("BioHarvest" or the... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 1, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2 nd to discuss recently announced milestone achievements, including full year 2023 financial... Read More

FY 2023 Revenue Increased 2.3x to $12.7 Million USD The Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million and is providing Q2 2024 Revenue Guidance of $5.7-$6.0 million Management pursuing Nasdaq listing by end of year. General and Special meeting called to approve share consolidation and additional independent director to comply with Nasdaq listing requirements Vancouver, British Columbia... Read More

80,000 Square Foot (7,500 Square Meter) Property includes 12 GMP Clean Rooms, Laboratory and Office space, and can accommodate expanded 50 Ton Manufacturing facility New Production Technologies Implemented at this Campus will serve to optimize the planned US-based 150-ton manufacturing facility Vancouver, British Columbia and... Read More

Experienced Life Sciences Executive to Support Cosmeceuticals and Injectables Growth for New CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 21, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of experienced life... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 14, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it has been invited to participate in the Benzinga Virtual Healthcare Summit 2024 on March 20, 2024. Benzinga's Virtual Healthcare Summit is an... Read More

Management Adding Critical Leadership Roles to Support Growth of Recently Launched CDMO Business Unit Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced the appointment of two senior hires in the areas of... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on March 12-13, 2024. CEO Ilan Sobel is scheduled to host... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update webinar on Wednesday, March 13 th to discuss the Company's Contract Development and Manufacturing Organization... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 26, 2024) - BioHarvest Sciences Inc. , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering the Botanical Synthesis process technology, has announced the official launch of its new Contract... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 20, 2024) - BioHarvest Sciences Inc. , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), is issuing this news release to expand on and clarify its news release issued February 15, 2024 the "Original Release" regarding engagement of MZ Group, at the request of CIRO. Additional Information to Original Release Under the terms of the... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 15, 2024) - BioHarvest Sciences Inc . , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ will work closely with... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2024) - BioHarvest Sciences Inc . , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and sponsorship of the 2024 BIO CEO & Investor Conference, which will take place in New York... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc. , (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company"), a pioneer in Botanical Synthesis technology that grows active Phyto-nutrient compositions without growing the plant, has issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholder Partners, 2023... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second and final tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. In this tranche closed Friday December 22,... Read More

VINIA Superfood Coffee will be a unique disruptor in the $6B US coffee pod market First of three Major "VINIA Inside" Products to be Launched Q4 2023 corporate revenue range guidance of USD 4.2M - 4.5M Further validation of the Botanical Synthesis Technology Platform Vancouver, British Columbia and Rehovot, Israel--(Newsfile... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 1, 2023) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) announces that it is hosting the Q3 Performance Update Presentation on Wednesday, December 13, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by Ilan Sobel, CEO of BioHarvest Sciences. "I am currently in Nashville, Tennessee, as... Read More

Q3 VINIA® revenues of USD 3.24M represent growth of 113% compared to Q3 2022 and 18% increase compared to Q2 2023 Year over Year Q3 Gross Profit improved from 18% to 45% Q4 2023 revenue range guidance of USD 4.2M - 4.5M VINIA® total active subscriber count grew by 213% Year over Year Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 29, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF)... Read More

MIAMI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64 th Emerging Growth Conference on November 1 st and 2 nd , 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 19 and October 20, 2023. The Company has issued Notes in the aggregate principal... Read More

Significant milestone marking the beginning of VINIA ® geographical expansion beyond Israel and the US Further validation from global health authorities of BioHarvest's Botanical Synthesis Technology Platform Canadian Sales and Marketing to begin in early 2024 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 10, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or... Read More

Significant milestone demonstrating sales momentum of VINIA ® Further validation of the Botanical Synthesis Technology Platform Strong justification of the Direct-to-Consumer sales strategy Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 6, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that US sales of its flagship product VINIA®... Read More

Q2 VINIA® revenues of USD 2.75M represent growth of 228% compared to Q2 2022 and 27% compared to Q1 2023 Year over Year Q2 VINIA total active subscriber count grew by 620% Consumer average rating of 4.8/5 sets VINIA as a leader in the category Q3 2023 revenue range guidance of USD 3M - 3.5M Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 30, 2023) - BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB:... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 24, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") announces that it is hosting the Q2 Performance Update Presentation on Wednesday, September 6, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by CEO Ilan Sobel. Mr. Sobel will discuss the Q2 financials announced this coming... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed its non-brokered private placement of convertible notes (the "Notes") previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of CA$4,642,075.50. The Company has... Read More

Dr. Brian Cornblatt shared how his misdiagnosis for MS brought him to the nutraceutical industry Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 30, 2023) - Dr. Brian Cornblatt, the Chief Medical Officer of BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the company"), delivered a keynote address on the "HealthConf" stage at the Collision conference in Toronto on Thursday.... Read More

Dr. Brian Cornblatt will give the keynote address on the "HealthConf" Stage at Collision Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer, Dr. Brian Cornblatt, will deliver... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, England. BioHarvest Sciences CEO Ilan Sobel will be attending this prestigious industry conference as an invited speaker, and he will... Read More

Celebrating two years since launch of VINIA® into the US New categories have potential for significant impact on financial results starting in Q1/2024 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") has unveiled a plan to enter new consumption categories where VINIA will be incorporated to create... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 6, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) announces that it has added Dr. John Paul SanGiovanni, world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory board. Dr. SanGiovanni will act as a liaison with the spheres of Academia, Industry, and Government, helping spread the promise and potential of... Read More

VINIA® revenues grew 209% compared to Q1 2022 to reach USD 2.2 M Reiterating guidance for year-on-year revenue growth of 3 X to reach USD 17M+ Gross margins continue to improve towards target required to achieve projected cash flow break even in Q4 2023. Reduction in marketing expenses as percentage of revenue demonstrating improved sales efficiency Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 31,... Read More

4.7/5 average rating based on over 2000 verified online customer reviews Over 25,000 new US customers and 50,000+ total orders in last 365 days All 5 "Team VINIA" 2023 NFL draft prospects found NFL teams Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 4, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) has surpassed 2,000 verified online reviews for its flagship product, VINIA, following the... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 3, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards . This annual Fast Company award celebrates “the... Read More

VINIA will be provided to over 140 NFL athletes preparing for the 2023 NFL Season Five House of Athlete Combine Trainees are heading into the 2023 NFL Draft as members of "Team VINIA" Bioharvest Sciences looks to make an impact by educating athletes and fans on the importance of heart health Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 27, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 26, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or the "Company") announces that it is hosting a Shareholder Presentation on Thursday May 4, 2023, at 11am PST | 2 pm EST. The interactive session will be hosted by CEO Ilan Sobel, who will be joined by Chief Medical Officer Dr. Brian Cornblatt. Ilan Sobel will provide updates... Read More

Move reinforces the Company's commitment to further scale its manufacturing capabilities by increasing production capacity, diversifying products and geographic markets, and by maintaining quality assurance while lowering production costs. Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 19, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company") has hired,... Read More

Multi tiered VINIA marketing campaign includes television and digital layers Campaign builds brand platform of Real People, Real Results, Real Science Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 4, 2023) - BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (the Company) is announcing that its first... Read More

Funds will also support the R&D program for potentially availing Active Pharmaceutical Ingredients (APIs) to the pharmaceutical industry with compositions based on its botanical synthesis technology 2 years 9% interest notes with conversion at a share price of no less than CAD $0.32 Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - February 21, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)... Read More

NFL wide receiver-turned-trainer Yo Murphy educates players on the importance of using science-based solutions like VINIA ® to optimize their heart health and general wellness during and after sports career VINIA® selected to optimize players' blood flow and delivery of oxygen to their body via its unique ability to increase dilation of arteries VINIA® and its benefits to be made available to athletes in current capsule form... Read More

Study will assess the Capacity of its Red Grape Cell (RGC) Botanical Composition to Promote Eye Health Study is first to demonstrate potential capabilities of BioHarvest's Botanical-Synthesis t echnology to provide consistent APIs, adjuvants and drugs for pharmaceutical industry Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - February 14, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)... Read More

Finished 2022 with Q4 sales orders of USD 2.7M representing a 3.3X increase over Q4 2021 Sales orders growth for 2023 is projected to be 3X of 2022 and reach USD 17.3M – USD 20.3M Cash flow break even projected for Q4 2023 Reassessment of commercialization timing of Cannabis and Hemp products Vancouver, British Columbia and... Read More

Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors. His appointment demonstrates the company's resolve to leverage its biotechnology platform for enabling drugs development. Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 17, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "company") announces... Read More

Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - January 11, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, January 19, 2023, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host this first shareholder... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 29, 2022) - BioHarvest Sciences Inc . ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel. Dear Shareholder Partner, What a year 2022 was for BioHarvest! We made big steps in our journey to build a multi-billion-dollar biotech company with a clear... Read More

Cash flow break-even projected for Q4 2023 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or "the Company") is estimating 2023 revenue to be between USD $17M-20M, representing a significant growth of at least 3X over 2022. Revenue for 2022 is now estimated to be USD $5.5M-$5.7M, meeting the guidance range provided by... Read More

BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV), a leading biotech company focused on plant bio-cells growth for the nutraceutical and the medicinal cannabis markets, today announced the signing of a binding Letter of Intent (LOI) with Royal Emerald Pharmaceuticals (REP), one of only seven Drug Enforcement Administration (DEA) bulk manufacturing registration holders permitted to grow marijuana in the United States... Read More

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the second tranche (the "Second Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on October 7, 2022. Due to the significant demand for this... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO Ilan Sobel will host an online investor presentation on Wednesday, November 16. Following the October 25th breakthrough achievement and other important recent developments at BHSC and in the Cannabis market, the Company invites all interested investors and media to register for this event, where Ilan Sobel will... Read More

BioHarvest demonstrates unprecedented Cannabinoids tuning and elicitation capabilities (12X increase versus original plant) using its proprietary Bio-Plant CELLicitation™ platform technology Contains high amounts of minor Cannabinoids such as THCV (2.5%) and CBDV (4.4%) providing unique medical and commercial benefits The... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on April 7, 2022 and October 7, 2022. Under the First Tranche, the Company has issued Notes in the aggregate principal amount of $6,878,243.65 CAD. In... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that its non-brokered private placement of convertible notes (the "Notes") previously announced of up to $6,300,000 CAD has been oversubscribed and has now been increased to up to $10,000,000 CAD in order to further accelerate VINIA® sales growth and Cannabis commercialization activities in North America. The... Read More

VINIA® sales orders reached a record high of USD 1.71M representing 145% growth compared to Q3 2021 and 81% growth compared to Q2 2022 Q3 Sales in the US delivered 3X the sales of Q2 2022 and crossed the USD 1 Million mark Strong sales momentum and increase in subscribers support guidance to achieve USD 5M-7M sales orders in in 2022, and cash flow positive in 2023 Unique Cannabis composition (analysis performed by... Read More

The award recognizes the sustainability impact of BioHarvest's Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without growing the plant itself BioHarvest Sciences receives the award with other industry thought leaders such as AstraZeneca, Agilent, and Honeywell Business Intelligence Group has named BioHarvest Sciences (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) as a winner of its 2022... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has announced the first multimedia campaign for VINIA™ in the USA, Phase 1. The company is scaling up its US marketing in line with a 2022 growth plan that aims for significant growth in sales orders following commercial entry in 2021. "We are delighted to launch our first integrated marketing campaign aimed at expanding our loyal... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") ") is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol "CNVCF". " Admission to the OTCQB® market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our investor... Read More

Purchase order of 1,000 kg for prompt delivery to support the growing demand for VINIA® Pipeline of 6 major customers testing VINIA® for inclusion in their final products Favorable terms of Purchase Order reflect the increasing value of the product and substantially contribute to BioHarvest's top line BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") today announced that Batory... Read More

VINIA® sales orders reached a record high of USD 947k representing 99% growth compared to Q2 2021 and 24% growth compared to Q1 2022 BioHarvest reiterates guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7M Started production of VINIA® at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to Cannabis Applied for the Cannabis production... Read More

Gavriel Lambert's 27 years of investment banking experience, covering the consumer and retail sectors and working on numerous capital markets transactions including IPOs, financings and M&A, will significantly enhance the Board of Advisors. His appointment continues to demonstrate the Company's resolve to partner with top life science and Cannabis companies. BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities, with... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has hired Dr. Brian S. Cornblatt as its Chief Medical Officer, marking a significant milestone in the Company's route for the development of next generation therapeutic solutions including botanical drugs. Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In... Read More

Full spectrum profile to include major and minor Cannabinoids as well as Terpenes Unique trichome structure provides for potentially higher solubility and bio-availability With Trichomes representing 93% of the Cannabis biomass produced using the proprietary Bio-Plant CELLicitation™ technology, taste bitterness is significantly reduced BioHarvest Sciences Inc. the (CSE: BHSC) ("BioHarvest" or the "company") today unveiled... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) ( FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing plan based on a private placement of up to USD $5 Million (approximately $6.3 Million CAD). The funds raised will allow the Company to accelerate the growth plan for its polyphenols/antioxidants and Cannabis verticals. On March 23, 2021 , BHSC announced the completion of the Company's Cannabis R&D program,... Read More

VINIA® sales orders grew 112% compared to Q1 2021 to reach USD 787k Reiterating guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7M Started the transition of VINIA® production at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to Cannabis Produced a unique Cannabis composition in large industrial scale Bioreactors enabling the... Read More

Now producing Cannabis biomass in large scale industrial bioreactors under the current R&D license. Commencing the process of transitioning the current Israeli Cannabis R&D license to a production license. BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") today announced that it has produced Cannabis Biomass in large scale industrial bioreactors, which represents the completion of the Company's Cannabis... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include an unveiling of the 2022 Growth Priorities, including a detailed performance update on the... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") has announced the new trademark for its proprietary non-GMO Biotech platform technology. The new name, "Bio-Plant CELLicitation™," replaces "BioFarming" and underscores the potential for the technology to be used in the botanical drugs space. "The Bio-Plant CELLicitation™ proven platform technology allows us to address multiple market verticals with... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ( OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") a fast-growing Biotech firm listed on the Canadian Securities Exchange, has engaged the award winning New York City-based communications firm Thunder11 for Public Relations services. Thunder11, which has specializations in technology, healthcare, and public affairs, will be involved in raising BioHarvest's profile with media... Read More

2022 Revenue will include sales of VINIA® and Cannabis, both with high gross margins Major investments in the BioFarming platform and Intellectual property New patent application covers a 700% increase in Bioreactor production output BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") announces that following the successful over-delivery of revenue targets versus guidance provided in 2021, the Company is... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has announced its plan to build a production facility in Canada, as part of the next phase in the global expansion of its Cannabis vertical. To that end, the Company is exploring opportunities to acquire an existing licensed facility or a Licensed Producer (LP), which would enable the Company to use its BioFarming technology to produce and then sell unique... Read More

17% quarter-over-quarter growth with record VINIA® global sales orders in Q4 of USD 825k 485% year-over-year growth with total sales orders of USD 2.4M in 2021 Continued success in VINIA® US pilot with USD 325k in sales orders in Q4, a 27% growth over Q3 BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company")... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel. Dear friends, It is with great pleasure that I take this opportunity at the end of the year to summarize for our shareholder partners the major accomplishments of what has been an inspiring and transformative first full calendar year for me as CEO... Read More

Cannabis produced has a Trichomes density of up to 200 times greater than in a plant-grown product while solving major industry challenges of consistency, safety, and environmental sustainability The Company is ready to engage with key players in the global Cannabis industry BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest"... Read More

The new factory is ready to start production to meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility to a Cannabis production facility within H1, 2022 BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that the new manufacturing facility in Israel has obtained the GMP (Good Manufacturing Practices) certification from the Israeli Ministry of Health.... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") reports that recent research analysis provides additional support for anti-oxidation structure/function claims of VINIA®. This analysis, when added to the clinical study [1] conducted by the Company, provides a clear substantiation to BioHarvest's claims relating to anti-oxidation, lipid anti-oxidation, and scavenging free radicals. The Company studied five... Read More

Steven Lehrer's 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D. His appointment continues to demonstrate the Company's resolve to leverage its biotech technology platform in life science-based businesses. BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that effective immediately, Steven Lehrer will be serving... Read More

David Tsur's 40 years of Biotech experience further strengthens the Board at a critical phase of the Company's growth His appointment reinforces the Company's primary focus on becoming a Biotech leader, leveraging the power of its platform technology to disrupt multiple business verticals BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announced that David Tsur has agreed to serve as a... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announces an update to its forecast of 2021 annual sales orders for VINIA® in Israel. The Company has increased its 2021 sales orders forecast for Israel to US$ 1.6M - US$ 1.7M from the previous forecast of US$ 1.3M - US$ 1.5M announced in March 2021. The continued adoption of VINIA® in Israel demonstrates the health benefits and efficacy... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, October 14, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a detailed performance update on... Read More

BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) today announced another strong quarter, fueled by strong growth of VINIA® sales in Israel and the U.S. Q3 VINIA® pilot sales revenues were USD 688K representing 44% growth over Q2 2021 and 1,198% growth over Q3 2020. In Israel , the Company reports record... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces the closing of its second and final tranche of the private placement announced on August 4 th , 2021. Under this private placement, the Company issued a total of 7,781,375 units ("each a Unit') for proceeds of CAD$ 3,501,619 with net proceeds of CAD$ 3,484,849 after payment of commissions and finders fees of CAD$ 16,770. Under the first tranche... Read More

The Company is now growing Cannabis cells with trichomes in medium-scale bioreactors representing a 250x increase in scale On track for commercialization of Cannabis and Hemp based products in H1-2022 BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) is announcing today that it has successfully scaled its... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement (the "Private Placement") previously announced on August 4, 2021. Under the First Tranche, the Company has issued 6,845,368 units (each a "Unit") at $0.45 per Unit for gross proceeds of CAD$ 3,080,415.60, net CAD$ 3,066,850.60 after... Read More

First biotechnology company engaged in the production of Cannabis biomass and cannabinoids to publish an ESG report and commit to tangible, science-based targets BioFarming manufacturing process uses 99.99% less land than traditional outdoor agriculture, while generating no direct greenhouse gases "GHG" emissions, no hazardous waste, and producing 100% biodegradable wastewater Committed to further reducing its environmental... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 8, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a performance update on Israel VINIA® Q2 results... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that its flagship VINIA® product is the only dietary supplement available in the US market which has the capability for both reducing the endothelin 1 (ET1) enzyme as well as increasing the nitric oxide (NO) molecules, in order to increase the dilation of arteries and thereby improve blood flow. The presence of ET1 constricts the blood vessel,... Read More

BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) announces today that it has successfully performed certain critical tasks necessary for the completion of its Cannabis development program. The Company has been adapting its unique and proprietary BioFarming technology, which enables the production of... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that online sales of its flagship VINIA® product in the United States will commence at 8 A.M. Eastern Time on May 12, 2021, via its vinia.com website. This milestone represents a turning point for BioHarvest as it brings its flagship product to the United States, the largest market in the world for nutraceutical supplements. VINIA® is a product... Read More

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery. Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/ About the Benzinga... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announced today that sales orders of VINIA® in Q1/2021 reached an all-time high of US$ 377,756, representing a 17% increase over Q4/2020 sales orders, and a 668% increase over Q1/2020. The total number of VINIA® purchase orders in Q1/2021 also reached a new high of 2,190, an increase of 45% versus Q4/2020. The results in the Israeli market, with a... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 8, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a look forward to the imminent e-commerce launch for VINIA® in the United States, a review of Q1... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") announces the appointment of Scott McCune to its Board of Advisors. With the appointment of Scott, a highly experienced marketing professional, BioHarvest has succeeded in assembling a best-in-class team of expert advisors to cover all the major aspects of the company's business. Scott will leverage his experience to assist the BioHarvest team in building a... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has received approval from the Ministry of Health in Israel to include VINIA®, its proprietary red grape cell product, in a health snack bar. This is an important development for BioHarvest as it introduces the Company's innovative and highly differentiated... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it is now trading on the Frankfurt Stock Exchange. BioHarvest Sciences Inc. is now listed on the Frankfurt Stock Exchange (also known as the Deutsche Boerse AG) under WKN: A2P3RM and the symbol 8MV. The company's shares continue to be listed on the Canadian Securities Exchange under the symbol C.BHSC. The Frankfurt listing will increase the... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives... Read More

This project will highlight the sustainability credentials and advantages of BioHarvest's BioFarming technology. BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it has entered into a partnership with BOLDT AG, an international business strategy and communications consultancy based in Europe, and Summit Strategy Group LLC, a U.S.-based communications firm, to develop BioHarvest's global... Read More

This milestone is critical for the large-scale production of full-spectrum plant-based cannabis products and cannabinoids in liquid media bioreactors. BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it is now able to consistently grow Trichomes from multiple cannabis plant strains, in liquid media. Furthermore, BioHarvest is the world's first and only Company to successfully develop the... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it has signed a financial advisory agreement with Cukierman & Co. Investment House Ltd., a full service Israeli financial advisory firm with life sciences expertise and global capabilities, granting it a mandate to explore opportunities for the application of VINIA® as an adjuvant therapy in the treatment of type 2 diabetes patients. The... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", or "BioHarvest") announces that it has closed its private placement of units at $0.40 per unit previously announced on January 21, 2021. The private placement was oversubscribed by 449,829 units and the Company has determined to accept the oversubscriptions. A total of 15,449,829 units at $0.40 per unit were issued, for gross proceeds of $6,179,932. Net proceeds after... Read More

BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company"). The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common... Read More

BioHarvest Sciences Inc. (CSE: BHSC) (the "Company" or "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest's Growth Plan, which will include highlights of the 2020 milestones achieved, key... Read More